Suzuken Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
May 15, 2023 at 02:00 am EDT
Share
Suzuken Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 2,314,828 million. Net income was JPY 20,345 million.
Basic earnings per share from continuing operations was JPY 236.47.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.